- ISIN
- US58470H1014
- CUSIP
- 58470H101
- Sector
- Consumer Cyclical
- Industry
- Personal Services
- IPO Date
- Dec 31, 1993
Highlights
- Market Cap
- $121.29M
- Enterprise Value
- $69.78M
- EPS (TTM)
- -$1.82
- Total Revenue (TTM)
- $346.10M
- Gross Profit (TTM)
- $242.70M
- EBITDA (TTM)
- -$3.86M
- Year Range
- $9.22 - $15.46
- Target Price
- $12.00
- ROA (TTM)
- -7.94%
- ROE (TTM)
- -10.13%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MED Performance Chart
Medifast, Inc. (MED) is up 3.2% since the beginning of the year. At $11 per share, MED is trading 28.7% below its 52-week high of $15. Investors who bought $1,000 worth of MED shares 5 years ago would now be looking at an investment worth $44.
Loading charts...
Returns By Period
Medifast, Inc. (MED) has returned 3.18% so far this year and -22.01% over the past 12 months. Over the last ten years, MED has returned -7.79% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Medifast, Inc.
- 1D
- -0.18%
- 1M
- -12.47%
- YTD
- 3.18%
- 6M
- -2.74%
- 1Y
- -22.01%
- 3Y*
- -49.36%
- 5Y*
- -46.41%
- 10Y*
- -7.79%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
MED Monthly Returns History
Based on dividend-adjusted daily data since Dec 31, 1993, MED's average daily return is +0.26%, while the average monthly return is +2.70%. At this rate, an investment would double in approximately 2.2 years.
Historically, 46% of months were positive and 54% were negative. The best month was Jan 2000 with a return of +163.2%, while the worst month was Aug 1999 at -64.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.
On a daily basis, MED closed higher 43% of trading days. The best single day was Jun 6, 2000 with a return of +166.7%, while the worst single day was Dec 23, 1999 at -64.0%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 7.12% | -7.95% | -3.23% | 6.67% | 15.27% | -12.05% | 3.18% | ||||||
| 2025 | -10.90% | -8.54% | -6.13% | -2.52% | 7.08% | -0.14% | -1.99% | 1.89% | -2.57% | -12.07% | -8.74% | -2.64% | -39.39% |
| 2024 | -18.70% | -26.64% | -4.42% | -28.16% | -6.50% | -15.23% | 0.50% | -16.55% | 4.59% | -3.97% | 7.02% | -10.42% | -73.79% |
| 2023 | -3.38% | 0.61% | -5.95% | -11.59% | -14.13% | 19.33% | 10.56% | -17.22% | -9.41% | -7.60% | -4.02% | 1.27% | -38.34% |
| 2022 | -5.12% | -6.40% | -7.29% | 4.44% | -6.51% | 9.19% | -6.83% | -25.39% | -12.44% | 7.96% | 7.74% | -7.19% | -42.31% |
| 2021 | 19.52% | 7.81% | -15.74% | 7.21% | 46.31% | -14.37% | 0.89% | -20.18% | -14.92% | 1.88% | 4.82% | 2.48% | 9.36% |
Benchmark Metrics
Medifast, Inc. has an annualized alpha of 75.98%, beta of 0.75, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since December 31, 1993.
- This stock participated in 94.33% of S&P 500 Index downside but only 69.91% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 75.98%
- Beta
- 0.75
- R²
- 0.01
- Upside Capture
- 69.91%
- Downside Capture
- 94.33%
Return for Risk
Risk / Return Rank
MED ranks 19 for risk / return — in the bottom 19% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Medifast, Inc. (MED) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MED | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.56 | ||
| Sortino ratioReturn per unit of downside risk | -3.40 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.37 | -0.44 |
| Calmar ratioReturn relative to maximum drawdown | -0.59 | 2.78 | -3.38 |
| Martin ratioReturn relative to average drawdown | -1.00 | 12.44 | -13.44 |
Dividends
Dividend History
Medifast, Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.00 | $0.00 | $0.00 | $4.95 | $6.56 | $5.68 | $4.52 | $3.38 | $2.19 | $1.44 | $1.07 | $0.25 |
Dividend yield | 0.00% | 0.00% | 0.00% | 7.36% | 5.69% | 2.71% | 2.30% | 3.08% | 1.75% | 2.06% | 2.57% | 0.82% |
Monthly Dividends
The table displays the monthly dividend distributions for Medifast, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| 2025 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2024 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 2023 | $0.00 | $0.00 | $1.65 | $0.00 | $0.00 | $1.65 | $0.00 | $0.00 | $1.65 | $0.00 | $0.00 | $0.00 | $4.95 |
| 2022 | $0.00 | $0.00 | $1.64 | $0.00 | $0.00 | $1.64 | $0.00 | $0.00 | $1.64 | $0.00 | $0.00 | $1.64 | $6.56 |
| 2021 | $0.00 | $0.00 | $1.42 | $0.00 | $0.00 | $1.42 | $0.00 | $0.00 | $1.42 | $0.00 | $0.00 | $1.42 | $5.68 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Medifast, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Medifast, Inc. was 98.40%, occurring on Dec 23, 1999. Recovery took 755 trading sessions.
The current Medifast, Inc. drawdown is 96.26%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
1999 bear market1999 | -98.40%Dec 1999 | 5y 10mo | 3y 5d | 8y 10moFeb 1994 - Dec 2002 |
2026 bear market2026 | -96.76%Mar 2026 | 4y 9mo | — | 5y 23dJun 2021 - now |
2005 bear market2005 | -85.56%Mar 2005 | 1y 3mo | 1y 3mo | 2y 6moNov 2003 - Jun 2006 |
Financial crisis2007–2009 | -83.16%Nov 2008 | 2y 5mo | 9mo 29d | 3y 2moJun 2006 - Sep 2009 |
COVID crash2020 | -78.91%Mar 2020 | 1y 6mo | 10mo 13d | 2y 4moSep 2018 - Jan 2021 |
Drawdown Indicators
| MED | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.40% | -56.78% | -41.62% |
Max Drawdown (1Y)Largest decline over 1 year | -37.39% | -9.10% | -28.29% |
Max Drawdown (3Y)Largest decline over 3 years | -90.91% | -18.90% | -72.01% |
Max Drawdown (5Y)Largest decline over 5 years | -96.29% | -25.43% | -70.86% |
Max Drawdown (10Y)Largest decline over 10 years | -96.76% | -33.92% | -62.84% |
Current DrawdownCurrent decline from peak | -96.26% | -1.80% | -94.46% |
Average DrawdownAverage peak-to-trough decline | -50.87% | -10.71% | -40.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.13% | 2.03% | +20.10% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Medifast, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Medifast, Inc. is priced in the market compared to other companies in the Personal Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MED relative to other companies in the Personal Services industry. Currently, MED has a P/S ratio of 0.4. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for MED in comparison with other companies in the Personal Services industry. Currently, MED has a P/B value of 0.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with MED
Add Medifast, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MED